Early peanut introduction tied to big drop in childhood food allergies, CHOP study finds
A 2025 Children’s Hospital of Philadelphia analysis of more than 120,000 pediatric electronic health records found early peanut introduction coincided with a 27% fall in peanut allergy diagnoses and about a 38% decline in overall IgE-mediated food allergies.
Key takeaways
- Large observational analysis: CHOP researchers examined over 120,000 pediatric records and reported a 27% drop in peanut allergy diagnoses and a ~38% drop in overall IgE-mediated food allergies after adoption of early-feeding guidance.
- Guideline-driven change: Trends were evaluated in the two years after the 2017 NIAID guidance recommending early peanut introduction for high‑risk infants.
- Association, not proof: The study is observational and used clinic records rather than individual feeding logs, so causation cannot be confirmed.
- Public-health potential: Experts say findings support scaling early-introduction guidance and clinician training to reduce population allergy burden.
What the CHOP study found
A CHOP-led team reviewed electronic health records from dozens of U.S. pediatric practices and compared rates of new food-allergy diagnoses before and after clinicians adopted the 2017 NIAID guidance endorsing early peanut introduction. The investigators observed a 27% decline in peanut allergy diagnoses and about a 38% decline in overall IgE‑mediated food allergies.
Lead author Stanislaw Gabryszewski, M.D., Ph.D., called the results evidence of a population-level public health impact from the change in infant-feeding advice. The researchers emphasize that the analysis shows an association coincident with guideline adoption rather than direct proof of causality.
Read the full release from Children’s Hospital of Philadelphia news release for details on methods and findings.
How this fits with earlier research
The CHOP findings build on the randomized LEAP trial (2015), which showed that giving peanuts to high‑risk infants between 4 and 11 months reduced peanut allergy risk by roughly 81% versus avoidance. LEAP helped prompt the 2017 NIAID guidance and later 2021 recommendations encouraging early introduction of multiple allergens.
Specialist endorsement: Professional groups see real-world support for prevention. The ACAAI statement notes that observational data now align with trial evidence that early introduction reduces peanut allergy risk.
Why early exposure may protect children
Allergy experts point to immune system learning: small, early oral exposures to peanut protein help the gut immune system recognize the food as harmless, lowering the chance of later overreaction and IgE-mediated allergy. The CHOP team and other allergy specialists cite this as a plausible mechanism for population-level declines.
Guidance for parents and clinicians
Current recommendations advise introducing peanut-containing foods around the time babies start solids, typically ~4–6 months. Infants with severe eczema or an existing egg allergy (considered high risk) may begin introduction as early as 4 months under pediatric guidance.
Use age-appropriate forms such as thinned peanut butter mixed into purees or peanut-containing puffs; avoid whole peanuts because of choking risk. Parents with concerns should consult a pediatrician about testing or supervised introduction.
See reporting on parental awareness and guidance from Lurie Children’s reporting on parental awareness for perspectives on public understanding.
Expert voices
Cherie Zachary, M.D., then-president of the American College of Allergy, Asthma & Immunology, described the CHOP-era data as “another piece of evidence that early introduction of peanut can prevent peanut allergy in many children.”
Pediatric allergists and researchers urge clinicians to incorporate specific counseling into well-baby care. Targeted training for primary-care teams may increase clinician adherence to guidance and boost early-introduction uptake, as shown in a Northwestern study on clinician training.
Study limits and unanswered questions
Key limitations: the CHOP analysis is observational and cannot prove causation. The data set ends in early 2019 (before the 2021 expansion of recommendations), so it does not capture later trends. Clinic records lack detailed feeding logs, preventing direct linkage of each child’s exposure history to outcomes. Undiagnosed cases or care provided outside participating practices could also affect counts.
“The analysis shows a promising association between guideline uptake and falling diagnoses, but other factors may have contributed,” the investigators note.
Public health and practice implications
Despite limitations, experts argue the results support emphasizing early peanut introduction as a public‑health strategy. Scaling education for parents and training for pediatric clinicians could reduce the population burden of peanut allergy, particularly where uptake has lagged.
The National Peanut Board has noted the potential for public-health benefit from wider early-introduction adoption.
Practical tips for parents
- Discuss solids at 4 months: Raise allergen-introduction plans during routine well-baby visits near 4 months.
- Use safe forms: Offer thinned peanut butter mixed into purees or peanut-containing puffs; never whole peanuts.
- High-risk infants: If the baby has severe eczema or egg allergy, seek pediatric or allergy-clinic advice before introducing peanuts.
Implications for the world
Early peanut introduction strategies may be applicable beyond the United States. Health systems in Europe, Asia, Africa and elsewhere facing rising childhood-allergy rates can consider incorporating early-introduction guidance into infant-feeding advice and primary-care workflows.
Social and cultural considerations: Messaging should be sensitive to local diets and beliefs, clearly explaining that early introduction is a preventive approach—not emergency treatment.
Economic, policy and social consequences
Economic: Fewer food‑allergy diagnoses could lower costs tied to emergency care, specialist visits and long‑term management; countries with universal child-health programs might see budgetary relief.
Policy: Governments and public-health agencies should consider updating infant-feeding guidance and training primary-care teams to deliver clear, evidence-based messages. Harmonized guidance across regions could speed adoption.
Social: Public-education campaigns should use clear, simple language and cultural sensitivity to help parents safely introduce allergens.
Practical steps for families worldwide
Primary-care teams should advise families at routine infant visits about starting solids at ~4–6 months and demonstrate safe forms of peanut. For infants with skin problems or other risk markers, clinicians should offer tailored plans, testing, or supervised feeding when needed.
